✦ LIBER ✦

Phospholipid determination in platelets, plasma and red cells of patients with chronic myeloproliferative disorders

✍ Scribed by Jesús M. Cesar; Ana Vecino; Mikel Perez-Vaquero; José L. Navarro

Book ID: 114791764
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 317 KB
Volume: 50
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1993.tb01926.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

JAK2-V617F mutation analysis of granuloc

JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets

✍ Kohtaro Toyama; Masamitsu Karasawa; Arito Yamane; Hiroyuki Irisawa; Akihiko Yoko 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Elevated plasma levels of TIMP-1 correla

Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders

✍ Morten Krogh Jensen; Mads Nikolaj Holten-Andersen; Rikke Riisbro; Peter de Nully 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

Use of whole blood platelet lumi-aggrego

Use of whole blood platelet lumi-aggregometry to optimize anti-platelet therapy in patients with chronic myeloproliferative disorders

✍ A. Manoharan; R. Gemmell; T. Hartwell 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

Application of analytical isotachophores

Application of analytical isotachophoresis in the study of platelet membrane proteins in patients with chronic myeloproliferative disorders

✍ Eiji Kajii; Shigenori Ikemoto 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 362 KB

Incidence and significance of theJAK2V61

Incidence and significance of theJAK2V617F mutation in patients with chronic myeloproliferative disorders

✍ S. E. Langabeer; F. Ni Ainle; E. Conneally; M. Lawler 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 166 KB

Relationship of thrombohemorrhagic compl

Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative disorders

✍ W. R. Friedenberg; R. C. Roberts; D. E. David 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

Thrombotic and hemorrhagic disorders are common complications of the myeloproliferative disorders. Endothelial cells release both procoagulant and profibrinolytic factors, which may contribute to these hemorrhagic or thrombotic complications. The pre-and postvenous stasis levels of the procoagulant